|Publication number||US3725556 A|
|Publication date||Apr 3, 1973|
|Filing date||Nov 12, 1970|
|Priority date||Nov 12, 1970|
|Publication number||US 3725556 A, US 3725556A, US-A-3725556, US3725556 A, US3725556A|
|Inventors||D Hanssen, A Knecht|
|Original Assignee||D Hanssen, A Knecht|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (12), Non-Patent Citations (3), Referenced by (28), Classifications (7)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent 1 Hanssen et al.
 METHOD OF MANUFACTURING RAPIDLY DISINTEGRATING PHARMACEUTICAL TABLETS  Inventors: Dieter Hanssen, Rotweinstrasse 24,
Ingelheim/am Rhine; Adolf Knecht, Im Breitle 3/a, Munzingen, both of Germany  Filed: Nov. 12, 1970  Appl. No.: 89,120
Related U.S. Application Data  Continuation-impart of Ser. No. 779,269, Nov. 26,
 U.S. Cl. ..424/357, 424/360, 424/361,
 Int. Cl. ..A01n 9/00  Field of Search ..264/117, 121-123;
 References Cited UNITED STATES PATENTS 3,293,132 12/1966 Stoyle et al. ..424/361 X 2,798,838 7/1957 Robinson ..424/ X 3,079,303 2/1963 Raff et a1 ...424/363 X 3,134,719 5/1964 Sheth et al ..424/366 X 3,424,842 1/1969 Numberg ..424/357 X 3,101,299 8/1963 Ferrand ..424/357 X 3,266,992 8/1966 de Jong ..424/362 X 2,851,453 9/1958 Kennon et al. ..424/362 X 3,034,911 5/1962 McKee et a1. ..424/361 X I 2,887,439 5 1959 Kiloze etal. ..424/361 X 3,490,742 1/1970 Nichols et al. ..424/361 X 1 Apr. 3, 1973 3,622,677 l'1/1971 short et a1 ..424/361 OTHER PUBLICATIONS Raff at al. J. Pharm. Sci. 76-79 (1961) I Scott et al. J. Pharm. Sci. 53; 670-675 (1964) Komblum J'- Pharm. Sci. 58: 125-127 (1969) Primary Examiner-Shep K. Rose Attorney-Hammond and Littell  ABSTRACT A method of compounding the inert pharmaceutical carrier ingredients and active drug ingredient of a pharmaceutical tablet composition, which circumvents the conventional granulation step prior to compression in the manufacture of pharmaceutical tablets and results in very rapidly disintegrating tablets; the method consists of 1. spray-drying, after inert gas foaming, a suspension of A. l 20 percent by weight of very finely divided silicon dioxide or aluminum oxide and Y B. 60 98 percent-by weight of at least one finegrained, inert filler material chosen from the group consisting of selected from the group consisting of substantially water-insoluble rice starch and corn starch and alkaline earth metal phosphates, in an aqueous solution of C. 1 20 percent of a water-soluble binder, 2. adding the active drug ingredient to the resulting spray-dried, unfiranulated tablet pregnix, and 3. compressing t e resulting composition together with the active agent and a tablet lubricant, into pharmaceutical tablets.
5 Claims, No Drawings METHOD OF MANUFACTURING RAPIDLY DISINTEGRATING PHARMACEUTICAL TABLETS This is a continuation-in-part of copending application Ser. No. 779,269, filed Nov. 26, 1968, now abandoned.
This invention relates to a novel method of com pounding the inert pharmaceutical carrier ingredients and active drug ingredients of a pharmaceutical tablet composition, which circumvents the conventional grnulation step prior to compression in the manufacture of pharmaceutical tablets and results in very rapidly disintegrating tablets exhibiting very desirable properties, especially with respect to oral administration of drugs to infants and small children.
BACKGROUND OF THE INVENTION AND STATE OF THE ART Pharmaceutical tablets are usually prepared from a mixture which, in addition to one or more active drug ingredients, contains a number of therapeutically inert, physiologically compatible carrier components which serve as diluents, adsorbents, agglutinants, disintegration promoters, lubricants and the like. These ingredients are generally first intimately admixed with each other, the mixture is granulated, and the granulate is then compressed into tablets with the aid of a conventional tablet-making machine.
It is also known that the granulating step can be circumvented by subjecting the inert ingredients or a mix ture thereof and the active ingredient to a spray-drying treatment [see Raff et al., J. Pharm. Sci. 50 1961 76;
Gunsel and Lachmann, ibid. 52 (1963), 178; and U.S. Pat. No. 3,293,132]. However, since spray-drying is a relatively expensive procedure, this method has until now not displaced the conventional granulating step in the manufacture of pharmaceutical tablets.
THE INVENTION We have discovered that by applying the spray-drying procedure to a very particular combination of inert pharmaceutical carrier ingredients it is not only possible to avoid the granulation step but also to produce pharmaceutical tablets having such uncommonly favorable properties that the application of this more costly procedure becomes justifiable for certain particular cases.
In heretofore conventional pharmaceutical tablet compositions the achievement of a satisfactory disintegration rate of the tablet is often predicated upon the incorporation of disintegration promoters which, upon coming in contact with water or aqueous liquids, channel the water as rapidly as possible into the center of the compressed tablet and then undergo swelling with the water and thus cause a bursting of the compacted bond of the tablet. However, due to the nature of the active ingredient, a satisfactory and rapid disintegration is sometimes difficult to achieve or not achievable at all; in some instances disintegration periods of up to half an hour or more must be accepted.
In accordance with the present invention we provide a pharmaceutical tablet composition which, when compressed into pharmaceutical tablets in conventional manner in a tablet-making machine, is capable of channeling the water toward the center of the tablet very rapidly and, in addition, producing extraordinarily good disintegration within a very short period of time.
The disintegration periods achieved thereby are generally less than one minute and in every case do not exceed the span of 2 or 3 minutes.
The method according to the present invention has the further advantage that it may be employed for the manufacture of rectal tablets and of tablets which, upon addition of a small amount of water, rapidly form a smooth and homogeneous slurry or, upon addition of somewhat larger amounts of water, rapidly form a potable suspension. The employment of a tablet containing an exact dose of an active ingredient as a means which immediately yields a slurry that is tolerated by infants and small children upon being admixed with a small amount of water or a potable suspension upon being stirred with somewhat more water, represents a substantial broadening of the spectrum of application of drugs. Thus, a so-called slurry-tablet must fulfill the following requirements:
1. It must, upon being brought in contact with a small amount of water (about twice the volume of the tablet), spontaneously and promptly disintegrate, i.e., within a few seconds or no more than a minute. 2. The slurry must be uniform, easily spreadable and smooth-tasting. 3. Upon further dilution with a little more water, so that the total volume does not exceed a few childs swallows, the slurry must be capable of being stirred into a substantially homogeneous and freeflowing suspension. 4. In place of with water, the slurry should also be dilutable or freely miscible with fruit juice, milk, baby cereal, cream of wheat or the like. The above requirements are fully met by pharmaceutical tablets manufactured by the method according to the present invention.
More particularly, the method of making pharmaceutical tablets pursuant to the present invention consists of l. spray-drying, after inert gas foaming, a suspension of A. l 20 percent by weight of very finely divided silicon dioxide or aluminum oxide and B. 98 percent by weight of at least one finegrained, inert filler material chosen from the group consisting of starches selected from the group consisting of substantially water-insoluble rice starch and corn starch, and alkaline earth metal phosphates, in an aqueous solution of C. 1 20 percent of a water-soluble binder,
2. adding the active ingredient to the resulting spraydried, ungranulated tablet pre-mix, and
3. compressing the resulting composition, together with the active agent and a tablet lubricant, into pharmaceutical tablets.
The disintegration properties of pharmaceutical tablets prepared by the method according to the present invention may be further improved by employing the spray-dried three-component mixture described of the finished pharmaceutical tablet inclusive of the active ingredient.
The silicon dioxide or aluminum oxide used as component (A) in the spray-drying step of the method according to the present invention should be provided in highly dispersed to colloidal form with a particle size of 100 mp, or a surface area of about 10 to 500 mlgm. Colloidal silicic acid sold under the name Aerosil is a particularly suitable example.
Component (B) is preferably provided in fine- -grained form with a particle size between 10 and 20 a.
Examples of water-soluble binders suitable for use as component (C) are water-soluble cellulose derivatives, such as hydroxyethylcellulose or carboxymethylcellulose, water-soluble starches such as amylum pectinum solubile, water-soluble plant gums such as gum arabic or tragacanth, alginates, gelatin and polyvinylpyrrolidone.
Of course, all of the components of the spray-dried tablet pre-mix must be chemically inert with respect to each other and therapeutically inert as well as physiologically compatible.
The size of the individual particles obtained from the spray-drying procedure lies generally between 10 and 70 u. The spray-dried, ungranulated tablet pre-mix according to the present invention is admixed with one or more active ingredients as well as with other optional adjuvents, and the mixture is then pressed into pharmaceutical tablets in conventional fashion. If the spraydried tablet pre-mix composition according to the present invention is used as the disintegration-promoting component in pharmaceutical tablets, the composition should advantageously constitute about 10 to 70 percent by weight of the finished tablet. in the case of so-called slurry-tablets the spray-dried three-com ponent tablet pre-mix composition, possibly in combination with the spray-dried two-component composition previously referred to, forms the major constituent of the tablet composition to which, in most cases, only the active ingredient needs to be added prior to making the tablet.
The preparation of the tablet pre-mix composition according to the present invention is, as indicated above, effected by subjecting a suspension of components (A) and (B) in an aqueous solution of component (C) to spray-drying. The water-soluble binder (C) should preferably be soluble in cold water and capable of swelling; particularly suitable is soluble starch (amylum pectinum solubile). In accordance with an illustrative embodiment of the process, the suspension of (A) and (B) in an aqueous solution of (C) is adjusted to a suitable viscosity, then foamed with an inert gas such as carbondioxide, and then spray-dried. The spray-drying may be effected in conventional spraydrying towers. The solids content of the suspension to be spray-dried lies advantageously between [5 and 50 percent by weight, and if the suspension is foamed with the inert gas the solids content is preferably from to 30 percent by weight.
A preferred tablet pre-mix composition according to the present invention contains, for example, 12 l8 percent by weight of colloidal silicic acid, 3 15 percent by weight of water soluble binder, and 67 85 percent by weight of water-insoluble rice starch or corn starch.
Analogous to the above-described process, a two component spray-dried composition, which is advantageously added to the three-component spraydried composition for the manufacture of slurrytablets, is obtained by suspending finely dispersed silicon dioxide or aluminum oxide in an aqueous solution of a swellable, water-soluble binder, such as a hydrophilic cellulose derivative, and thereafter spray-drying the suspension. A preferred two-component spraydried composition consists, for example, of percent by weight of colloidal silicic acid and 10 percent by weight of water-soluble binder.
The combination of the three-component spraydried composition with the two-component spray-dried composition produces a particularly advantageous tablet pre-mix composition for inclusion in pharmaceutical slurry-tablets.
The following examples further illustrate the present invention and will enable others skilled in the art to understand it more completely. It should be understood, however, that the invention is not limited solely to the particular examples given below. The parts are parts by weight.
EXAMPLE 1 Rapidly disintegrating pharmaceutical tablets were prepared from the following ingredients:
Parts Penicillin V potassium l45 sulfadimethoxine l 50 S ray-dried composition] 558 alcum 40 Colloidal silicic acid 20 Magnesium stearate l2 conventional 925 The spray-dried composition 1 was prepared in the following manner from the following ingredients:
Parts Substantially water-insoluble rice starch 70 Colloidal silicic acid 15 Soluble starch 15 Total The soluble starch was dissolved in hot water, the resulting solution was cooled to about 40 C., and then the silicic acid and the rice starch were stirred in. The suspension thus obtained was spray-dried in a convespray-drying tower with an entrance temperature of about 200 C. and an exit temperature of about 75 C.
The tablets were made in the following manner: The penicillin V potassium and the sulfadimethoxine were passed through a fine screen, thoroughly admixed with the other ingredients, and the resulting mixture was pressed into 925 mgm tablets with a diameter of 15 mm with the aid of a conventional tablet making machine. Each tablet contained mgm of penicillin V potassium and mgm of sulfadimethoxine and completely disintegrated within 2 to 3 minutes after coming in contact with water or an aqueous liquid.
EXAMPLE 2 Slurry-tablets were prepared from the following ingredients:
Parts Aspirin 300.0 Spray-dried composition I 88.0
S ray-dried composition ll 10.0 agnesium stearate 1.0 Cyclamate 0.6 Saccharin 0.4 Total 400.0
temperature of about 220 C. and an exit temperature of about 80 100 C.
The two spray-dried compositions were thoroughly admixed with each other as well as with the other tablet ingredients, and the mixture was pressed into 400 mgm-tablets. Each tablet contained 300 mgm of aspirin and, in contact with about twice its volume of water, disintegrated within less than a minute to form a smooth aqueous slurry.
EXAMPLE 3 Antibiotic slurry-tablets were prepared from the following ingredients:
Parts Spray-dried composition l 1 193.0 Spray-dried composition ll 150.0 Penicillin V potassium 133.0 Ma nesium stearate 15.0 Cyc amate/saccharin (2:1) 10.0 Total 1500.0
The spray-dried compositions l and II were the same as those in Examples 1 and 2, respectively. The ingredients were thoroughly admixed with each other, and the mixture was pressed into 1,500 mgm-tablets. Each tablet contained 132 mgm of penicillin V potassium and, in contact with about twice its volume of water, disintegrated within less than a minute to form a smooth aqueous slurry.
EXAMPLE 4 The same results were obtained as in Examples 1, 2 and 3 when the spray-dried composition I therein was replaced by one prepared from the following ingredients:
Parts Substantially water-insoluble rice starch 74 Colloidal silicic acid Soluble starch l0 Tragacanth 1 Total 100 replaced by one prepared according to Example 4 from the following ingredients:
Parts Com starch 73.5 Colloidal silicic acid 15.0 Soluble starch 10.0 Gum arabic 1.5 Total 100.0
EXAMPLE 6 The same results were obtained as in Examples 1, 2 and 3 when the spray-dried composition 1 therein was replaced by one prepared from the following ingredients:
Parts Calcium hydrogen phosphate, fine Colloidal silicic acid 10 Carboxymethyl cellulose 5 Total The carboxymethyl cellulose was dissolved in warm water, while vigorously stirring. After the carboxymethyl cellulose was thoroughly wetted throughout, the colloidal silicic acid and the finely divided calcium phosphate were stirred in, and the resulting aqueous suspension was spray-dried in customary fashion.
It should be understood that the physical properties of the active drug ingredient have no bearing upon the operativeness of the present invention. Thus, it is immaterial, for example, whether the active ingredient is water-soluble or not; the only criterion is that it must lend itself to incorporation into a pharmaceutical tablet. In other words, any active ingredient which is normally administered in tablet form may be combined with the spray-dried, ungranulated tablet pre-mix composition according to the present invention.
While the present invention has been illustrated with the aid of certain specific embodiments thereof, it will be readily apparent to others skilled in the art that the invention is not limited to these particular embodiments, and that various changes and modifications may be made without departing from the spirit of the invention or the scope of the appended claims.
1. The method of manufacturing pharmaceutical tablets which spontaneously and completely disintegrate in water or in a potable aqueous liquid within 2 or 3 minutes by a process wherein the conventional granulation step prior to the compression in the manufacture of pharmaceutical tablets is circumvented or displaced by subjecting the inert ingredients or a mixture thereof with one or more active ingredients to a spray-drying treatment, said process consisting of the steps of a. spraying-drying, after inert gas foaming, in a conventional spray-drying tower (A) as hereinafter defined and (B) as hereinafter defined in an aqueous solution of (C) as hereinafter defined, and then b. compressing the resulting composition, together with the active agent and a tablet lubricant, in a conventional tablet-making machine, into a quickly-disintegrating pharmaceutical compressed tablet consisting essentially of one or more active ingredients added prior to compression of the tablet, without granulation, to an ungranulated tablet pre-mix consisting essentially of (A) l 20 percent by weight of finely divided silicon dioxide or aluminum oxide,
(B) 60 90 percent by weight of at least one finegrained inert filler material selected from the group consisting of substantially water-insoluble rice starch or corn starch and alkaline earth metal phosphates, and
(C) 1 20 percent by weight of a water-soluble binder selected from the group consisting of hydroxyethyl cellulose, carboxymethyl cellulose, water-soluble starch, gum arabic, tragacanth, alginates, gelatin and polyvinylpyrrolidone.
- 2. The method according to claim 1, wherein com- 1 3 UNITED STATES PATENT omen CERTIFIQATE OE CQRRECTION Pateot No. 3,725,556 "Dated Apr l 3, 1973 Inventor) DIETER HANSSEN and ADOLF KNECH'I' It is certified that error appears in the aboveidentified patent and that said Letters Patent are hereby corrected as shown below:
lnsert -- Assignee: BOEHRINGER INGELHEIM GrhbH "1 Ingelheim/Rhein, Germany In line 1 1 5f the ABSTRACT insert --starches-- before "selected" 0'01; l,v lines l8- l9 correct "conves pray to read --conventional spray-- Col. 6, line 53 correct "spraying to read -'-sp'ray--.
Signed and sealed this 23rd day of April 1971 (SEAL) r Y Attestz EDWARD I-LFLETUIERJR. c. MARSHALL DAHN Attesting Officer 'Gommission'er of Patents.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2798838 *||Nov 10, 1954||Jul 9, 1957||Smith Kline French Lab||Method of preparing acetophenetidin tablets|
|US2851453 *||Aug 9, 1954||Sep 9, 1958||Smith Kline French Lab||Cellulose derivative product, compositions comprising the same and their preparation|
|US2887439 *||Sep 28, 1956||May 19, 1959||Pfizer & Co C||Palatable antihistamine tablet|
|US3034911 *||Mar 25, 1959||May 15, 1962||Nat Starch Chem Corp||Tablet disintegrants|
|US3079303 *||Dec 11, 1958||Feb 26, 1963||Smith Kline French Lab||Basic tablet granulation and process of using same|
|US3101299 *||Oct 30, 1961||Aug 20, 1963||Parisienne D Expansion Chimiqu||Silica-gel powder tablet compositions|
|US3134719 *||Apr 5, 1962||May 26, 1964||American Cyanamid Co||Calcium phosphates in tablet compressing|
|US3266992 *||Jan 22, 1963||Aug 16, 1966||Organon Nv||Tablets and method of preparing the same|
|US3293132 *||Mar 25, 1963||Dec 20, 1966||Merck & Co Inc||Spray dried vitamin compositions and method of preparation|
|US3424842 *||May 4, 1965||Jan 28, 1969||Merck Ag E||Manufacture of tablets directly from dry powders|
|US3490742 *||Jan 14, 1966||Jan 20, 1970||Staley Mfg Co A E||Compressed tablets|
|US3622677 *||Jul 7, 1969||Nov 23, 1971||Staley Mfg Co A E||Compressed tablets containing compacted starch as binder-disintegrant ingredient|
|1||*||Kornblum J. Pharm. Sci. 58: 125 127 (1969)|
|2||*||Raff et al. J. Pharm. Sci. 50; 76 79 (1961)|
|3||*||Scott et al. J. Pharm. Sci. 53; 670 675 (1964)|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4016254 *||Apr 5, 1976||Apr 5, 1977||Beecham Group Limited||Pharmaceutical formulations|
|US4017598 *||Apr 22, 1975||Apr 12, 1977||Shin-Etsu Chemical Company Limited||Preparation of readily disintegrable tablets|
|US4086335 *||Oct 29, 1975||Apr 25, 1978||Bruscato Frank N||Pharmaceutical tablets containing chitin as a disintegrant|
|US4209513 *||Apr 14, 1978||Jun 24, 1980||Burroughs Wellcome Co.||Tablet formulation|
|US4254099 *||Oct 1, 1979||Mar 3, 1981||Beiersdorf Aktiengesellschaft||Pharmaceutical tablet composition|
|US4264573 *||May 21, 1979||Apr 28, 1981||Rowell Laboratories, Inc.||Pharmaceutical formulation for slow release via controlled surface erosion|
|US4369308 *||Jul 24, 1981||Jan 18, 1983||National Starch And Chemical Corporation||Low swelling starches as tablet disintegrants|
|US4601895 *||Dec 6, 1984||Jul 22, 1986||Bayer Aktiengesellschaft||Delayed-action acetylsalicylic acid formulations for oral administration|
|US4617294 *||Apr 22, 1985||Oct 14, 1986||Ppg Industries, Inc.||Animal feed supplement|
|US4684534 *||Feb 19, 1985||Aug 4, 1987||Dynagram Corporation Of America||Quick-liquifying, chewable tablet|
|US4830859 *||Sep 30, 1987||May 16, 1989||Basf Corporation||Process for lubricating water-soluble vitamin powders|
|US4940588 *||Mar 17, 1988||Jul 10, 1990||Elan Corporation||Controlled release powder and process for its preparation|
|US4952402 *||Mar 17, 1988||Aug 28, 1990||Elan Corporation, P.L.C.||Controlled release powder and process for its preparation|
|US5047246 *||Sep 9, 1988||Sep 10, 1991||Bristol-Myers Company||Direct compression cyclophosphamide tablet|
|US5747068 *||Jul 18, 1995||May 5, 1998||Lilly S. A.||Flouxetine pharmaceutical formulations|
|US5807577 *||Nov 22, 1995||Sep 15, 1998||Lab Pharmaceutical Research International Inc.||Fast-melt tablet and method of making same|
|US5888548 *||Aug 27, 1996||Mar 30, 1999||Erawan Pharmaceutical Research And Laboratory Company Limited||Spherically agglomerated starches with silicon dioxide|
|US5989589 *||Oct 24, 1997||Nov 23, 1999||Cartilier; Louis||Cross-linked cellulose as a tablet excipient|
|US6080427 *||Mar 17, 1998||Jun 27, 2000||Bristol-Myers Squibb Company||Cefadroxil monohydrate tablet formulation|
|US6716453||May 22, 2000||Apr 6, 2004||Verion, Inc.||Method for increasing the active loading of compressible composition forms|
|US7037530||Apr 23, 2002||May 2, 2006||Pfizer Inc||Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency|
|US7176221||Dec 13, 2005||Feb 13, 2007||Pfizer Inc.||Low dose pharmaceutical composition having uniform drug distribution and potency|
|US20030004182 *||Apr 23, 2002||Jan 2, 2003||Gierer Daniel S.||Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency|
|US20040241247 *||Aug 23, 2002||Dec 2, 2004||Sheskey Paul J||Process for dispersing a fluid in solid particles|
|US20050186271 *||Feb 24, 2004||Aug 25, 2005||Sheskey Paul J.||Process for dispersing a fluid in a mass of solid particles|
|US20100055265 *||Oct 16, 2009||Mar 4, 2010||Rhodia Chimie||Compound consisting of precipitated silica and phosphate and use thereof as nutrient intake liquid support and as anticaking agent with nutrient intake|
|EP0823439B1 *||Aug 9, 1996||Jan 24, 2001||Erawan Pharmaceutical Research and Laboratory Company Limited||Improvements in or relating to agglomeration of starch|
|WO2004022216A1 *||Aug 21, 2003||Mar 18, 2004||Rhodia Chimie||Compound consisting of precipitated silica and phosphate and use thereof as nutrient intake liquid support and as anticaking agent with nutrient intake|
|U.S. Classification||514/770, 514/960, 514/778|
|Cooperative Classification||A61K9/2004, Y10S514/96|